The Peptide Lie: What a Drug Developer Reveals About the Compounds Everyone Is Injecting | Dr Leigh Baxt

April 21, 2026

AI Summary

5 min read

Dr. Leigh Baxt, a PhD in microbiology and immunology from Stanford who leads drug development at Memorial Sloan Kettering Cancer Center, has watched something unprecedented in her scientific career: millions of people injecting compounds labeled "for research purposes only, not for human use." She is not anti-peptide—she works on drug development daily—but she is deeply concerned that the wellness industry is selling therapies with no human data, no mechanistic understanding, and no regulatory oversight. The conversation walks through what the drug development process actually looks like, why most ideas fail, and what it means to accept unknown risk.

What a peptide actually is and what it isn't

Continue reading the full summary in the app — free to try.

Read Full Summary →

Free • No credit card required

Listen to Audio Summary Open in App

Never miss an episode of The Proof with Simon Hill

Get every new episode summarized in your inbox — free, ~5 minutes to read.

No spam. Unsubscribe anytime.

What you'll learn

1 (00:53) **Why a Drug Developer Took to Social Media** - Dr. Leigh Baxt explains her motivation for speaking out about the unregulated peptide market.
2 (03:10) **The Core Concern: Missing the Drug Development Process** - Why the lack of a standard development pathway for these peptides is dangerous.
3 (05:18) **The 10-15 Year Drug Development Journey** - A walkthrough of what it takes to get a drug from an idea to FDA approval.
4 (08:30) **Three Classes of Peptides: Approved, Gray Market, and "Research Only"** - A clear distinction between different types of peptides on the market.
5 (14:07) **The Marketing of "Research Only" Peptides** - How the sale of these compounds preys on vulnerable people and erodes trust.
6 (18:14) **The Reclassification Proposal: What It Does and Doesn't Mean** - Clarifying that a change in regulatory category is not a substitute for clinical trial data.
7 (21:42) **Potential Risks: The Unknown Unknowns** - Why the lack of molecular understanding makes it impossible to quantify risk.

+ Full timestamped outline available in the app

Show Notes

Peptides are being marketed as solutions for everything from injury recovery to longevity, but what does the science actually say?

In this episode, Dr Leigh Baxt joins me to break down what peptides are, how drug development really works, and why so many of the claims circulating online are running far ahead of the evidence. We explore the difference between approved peptide medicines and unregulated products sold online, why anecdotes are not enough, and what people should understand before putting these compounds into their bodies.

What We Cover

What peptides are and why they are not new
FDA-approved peptide drugs versus unregulated peptides sold online
Why scientists are concerned about the current peptide boom
How drugs are developed and why most ideas fail
Why animal and cell studies are not enough to establish safety and efficacy
The problem with using “natural” as a proxy for safe
How to think critically about peptide marketing and anecdotal claims

This is an important conversation for anyone trying to make sense of the peptide boom and separate genuine science from wellness hype.

To learn more from Dr Leigh Baxt, follow her on Instagram at @sciencemomscicomm. I also recommend exploring Unbiased Science, where science communication is made far more accessible for the public. You can follow the project on Instagram, Threads, Facebook, LinkedIn, X, subscribe on Substack, and watch on YouTube.

The views expressed are her own and she is not representing her employer.

Intro (00:00)
Stanford Expert Breaks Down the Peptide Hype (00:53)
The Skill Set Behind Real Drug Development (05:09)
FDA Approved vs Research Only Peptides Explained (08:03)
Why Most Drug Candidates Never Become Medicine (11:06)
Peptide Reclassification What Changes and What Doesn't (15:59)
The Biological Risks Nobody Mentions About Peptides (20:36)
Why Natural Peptides Are Not Necessarily Safe (23:00)
What Safety Tests Drugs Must Pass First (28:51)
Accepting Unknown Risk What That Actually Means (33:31)
How to Find Credible Health Experts Online (36:13)
Why Drug Development Always Requires A Team (39:19)

Want to support the show?

The best way to support the show is to use t